UGSA Position Statements

COVID-19 Impact on Category 2 & 3 Elective Surgery

Updated 11.59pm 11 March 2020 
The attached guidelines have been developed by UGSA as a general guide to assist our Australian members to make an informed decision during the Covid-19 pandemic.  Each clinician should use these guidelines to help with decision making in conjunction with the individual patient’s circumstances. As the situation is continually changing and evolving, the advice may vary over the next few days. We will review the document periodically and will amend as and when required.
UGSA Statement on Surgical Guidelines During Covid-19 as of 27 March 2020

Credentialing Guidelines for Implant and Removal of Transvaginal Mesh

Updated 23 July 2019 
UGSA has recently been by the Australian Commission on Safety and Quality in Healthcare to request our support in raising awareness of their credentialing guidelines for the Implant and Removal of Transvaginal Mesh.
Please take the time to review the following guidelines: 
https://www.safetyandquality.gov.au/our-work/health-conditions-and-treatments/transvaginal-mesh/resources-consumers-clinicians-and-health-service-organisations-transvaginal-mesh

 

TGA Action Plan for Medical Devices - UGSA Statement 

Updated April 2019
The attached media release was issued by Dr Jenny King, UGSA Chair in response to the TGA Action Plan for Medical Devices.
TGA Action Plan April 2019

UGSA Statement on Mid-Urethral Slings

Updated July 2017
The attached statement was issued by Dr Alexandra Mowat, UGSA Secretary in response to the Mesh Senate Inquiry. 
UGSA Statement on Mid-Urethral Slings